All-time High Annual Revenue
Total sales for FY2025 grew 6% year-over-year to $5.5 billion, an all-time high for the company.
Core Sales and Recurring Revenue Strength
FY2025 core sales grew 4.7% year-over-year; recurring revenue comprised roughly 59%–60% of total sales, supporting durability.
Double-Digit Adjusted EPS Growth
Adjusted EPS for FY2025 was $3.90, up 10% year-over-year, marking the second consecutive year of double-digit EPS growth.
Robust Free Cash Flow and Strong Cash Position
Generated over $1 billion of free cash flow in FY2025. In Q4 alone free cash flow was $291 million (115% conversion of GAAP net income). Cash on hand at quarter-end was $2.0 billion with net debt of $642 million (net leverage 0.5x).
Q4 Profitability Expansion
Q4 gross profit increased 3.4% to $828 million with gross margin of 59.3%. Q4 adjusted operating profit grew 7% and margin expanded to 24.6% (up 80 basis points year-over-year). Q4 adjusted EPS was $1.04, up 9%.
Capital Allocation Actions
Board authorized a $750 million share repurchase program and raised the dividend by 18%, demonstrating confidence in cash generation and capital flexibility.
Strategic M&A Bolstering Portfolio
Completed acquisition of In-Situ (adds ~ $80 million sales in 2025; ~50% gross margins; mid-teens EBITDA margins) and earlier deals (AQUAFIDES, TraceGains) that accelerated product and market capabilities.
Product and R&D Momentum
New product launches contributed to growth: ammonia analyzer, double-digit growth in single-use Chemkeys, UV laser marking system, and AI-enabled packaging print solution—evidence of R&D payback.
Segment Operational Records
Both segments hit all-time highs: PQI nearly $2.2 billion in annual sales with $578 million adjusted operating profit; Water Quality delivered $858 million adjusted operating profit for the year.
2026 Guidance for Continued Growth and Margin Expansion
2026 guidance: core sales targeted in the low- to mid-single-digit range, total sales mid- to high-single-digit (including FX/acquisitions), adjusted EPS guidance $4.10–$4.20 (mid- to high single-digit growth), and targeted ~25 basis points of adjusted operating margin improvement.